消融联合化疗和单纯化疗在Ⅳ期胰腺癌治疗中的临床和实验研究
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

江苏省卫生健康委员会医学科研指导性项目(Z2021021)


The clinical and experimental study of ablation therapy combined with chemotherapy or chemotherapy alone in the treatment of stage Ⅳ pancreatic cancer
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:比较术中消融联合化疗和单纯化疗在Ⅳ期胰腺癌治疗中的效果,并初步探讨消融联合化疗的潜在细胞学机制。方法:入选南京医科大学第二附属医院收治的Ⅳ期胰腺癌患者,分为单纯化疗组(化疗组,n=13)与术中消融联合化疗组(消融组,n=14),分析患者临床资料,对比肿瘤指标、血常规指标及术后生存期等。同时,采用Boyden小室建立人胰腺癌细胞渗透性实验模型,探究超低温冷冻对人胰腺癌细胞渗透性的影响。结果:消融组治疗后总胆红素(total bilirubin,TB)显著低于化疗组,而白蛋白(albumin,ALB)显著高于化疗组(P < 0.01)。两组CA19-9在治疗前后均没有显著差异。消融组治疗前后的白细胞数和中性粒细胞百分比均低于化疗组(P < 0.05)。消融组治疗前血小板数高于化疗组(P < 0.05)。化疗组治疗后的红细胞数显著低于治疗前(P < 0.01)。消融组治疗后的中性粒细胞百分比显著高于治疗前(P < 0.01)。消融组术后的生存期显著优于化疗组(P=0.019)。经过超低温冷冻的胰腺癌细胞渗透性显著增强(P < 0.01)。结论:术中消融联合化疗较单纯化疗对Ⅳ期胰腺癌的治疗效果更好,患者生存期延长。

    Abstract:

    Objective:This study aims to compare the therapeutic effects of ablation therapy combined with chemotherapy and chemotherapy alone in the treatment of stage Ⅳ pancreatic cancer, and to explore the potential cytological mechanism of ablation therapy combined with chemotherapy. Methods:Patients with stage Ⅳ pancreatic cancer admitted to the Second Affiliated Hospital of Nanjing Medical University were divided into two groups:chemotherapy alone group(chemotherapy group,13 cases) and ablation therapy combined with chemotherapy group(ablation group,14 cases). The clinical data of patients were analyzed. The tumor indexes,routine blood indexes,and survival rate were compared between these groups. To study the role of ultralow temperature on the permeability of pancreatic cancer cells,the permeability assay of pancreatic cancer cells was set up based on Boyden chambers. Results:The postoperative total bilirubin(TB) in ablation group was lower than that in chemotherapy group,while the postoperative albumin(ALB) in ablation group was higher than that in chemotherapy group(P < 0.01). The levels of CA19-9 in two groups had no significant difference. The counts of both pre-treatmental and after-treatmental white blood cells and the percentages of neutrophils in ablation group were less than those in chemotherapy group(P < 0.05). The count of pre-treatmental platelet in ablation group was more than that in chemotherapy group(P < 0.05). In chemotherapy group, the count of after-treatmental red blood cells was less than the count of pre-treatmental red blood cells(P < 0.01). In ablation group,the percentage of after-treatmental neutrophils was higher than that of pre-treatmental neutrophils(P < 0.01). The survival of patients in ablation group was significantly longer than that in chemotherapy group(P=0.019). The permeability of pancreatic cancer cells was incresded after the treatment of ultralow temperature. Conclusion:The patients with stage Ⅳ pancreatic cancer have longer survival rates after the treatment of ablation therapy combined with chemotherapy.

    参考文献
    相似文献
    引证文献
引用本文

钱祝银,余建和,程 志,陈奕秋,朱一超.消融联合化疗和单纯化疗在Ⅳ期胰腺癌治疗中的临床和实验研究[J].南京医科大学学报(自然科学版),2022,42(6):849-853

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2022-01-09
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-06-21
  • 出版日期:
通知关闭
郑重声明